Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature.

Shaughnessy, Paul; Chao, Nelson; Shapiro, Jamie; Walters, Kent; McCarty, John; Abhyankar, Sunil; Shayani, Sepideh; Helmons, Pieter; Leather, Helen; Pazzalia, Amy; Pickard, Simon

Shaughnessy, Paul; Chao, Nelson; Shapiro, Jamie; Walters, Kent; McCarty, John; Abhyankar, Sunil; Shayani, Sepideh; Helmons, Pieter; Leather, Helen; Pazzalia, Amy; Pickard, Simon.

Affiliation

Shaughnessy P; Texas Transplant Institute, San Antonio, Texas, USA. Paul.Shaughnessy@MHShealth.com

Biol Blood Marrow Transplant ; 19(9): 1301-9, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23685251

Subject(s)

Hematopoietic Stem Cell Mobilization/economics; Hematopoietic Stem Cell Transplantation/economics; Economics, Pharmaceutical; Hematopoietic Stem Cell Mobilization/methods; Hematopoietic Stem Cell Transplantation/methods; Humans

Key words

Autologous; Costs; Failure to mobilize; Mobilization; Pharmacoeconomics; Plerixafor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematopoietic Stem Cell Mobilization Type of study: Health_economic_evaluation Limits: Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google